Skip to Content

barr 513 (Acetazolamide Extended Release 500 mg)

Pill with imprint barr 513 is Orange, Capsule-shape and has been identified as Acetazolamide Extended Release 500 mg. It is supplied by Teva Pharmaceuticals USA.

Acetazolamide is used in the treatment of glaucoma; hydrocephalus; edema; epilepsy; mountain sickness / altitude sickness and belongs to the drug classes carbonic anhydrase inhibitor anticonvulsants, carbonic anhydrase inhibitors. Risk cannot be ruled out during pregnancy. Acetazolamide 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for barr 513

Acetazolamide extended release 500 mg barr 513
Acetazolamide extended release 500 mg barr 513
Acetazolamide extended release 500 mg barr 513

Acetazolamide Extended Release

Imprint
barr 513
Strength
500 mg
Color
Orange
Size
23.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants, Carbonic anhydrase inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00555-0513
Inactive Ingredients
microcrystalline cellulose, sodium lauryl sulfate, magnesium silicate, D&C Red No. 28, D&C Yellow No. 10, FD&C Red No. 40, gelatin, titanium dioxide, aluminum oxide, FD&C Blue No. 1, FD&C Blue No. 2, shellac, propylene glycol, ferrosoferric oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.